Trial Profile
A MULTI-CENTRE, SINGLE DOSE TRIAL TO EVALUATE PHARMACOKINETICS OF PITOLISANT (BF2.649) IN CHILDREN FROM 6 TO LESS THAN 18 YEARS WITH NARCOLEPSY
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Sep 2017
Price :
$35
*
At a glance
- Drugs Pitolisant (Primary)
- Indications Narcolepsy
- Focus Pharmacokinetics
- Sponsors Bioprojet
- 12 Sep 2015 Status changed from recruiting to completed as per European Clinical Trials Database record.
- 04 Apr 2014 New trial record